Literature DB >> 21785549

Ulipristal Acetate (ella): A Selective Progesterone Receptor Modulator For Emergency Contraception.

Andrea Kim, Mary Barna Bridgeman.   

Abstract

Entities:  

Year:  2011        PMID： 21785549      PMCID： PMC3138379     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  5 in total

1.  Estimated pregnancy rates for the United States, 1990-2005: an update.

Authors:  Stephanie J Ventura; Joyce C Abma; William D Mosher; Stanley K Henshaw
Journal:  Natl Vital Stat Rep       Date:  2009-10-14

2.  Unintended pregnancy in the United States.

Authors:  S K Henshaw
Journal:  Fam Plann Perspect       Date:  1998 Jan-Feb

3.  Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.

Authors:  Anna F Glasier; Sharon T Cameron; Paul M Fine; Susan J S Logan; William Casale; Jennifer Van Horn; Laszlo Sogor; Diana L Blithe; Bruno Scherrer; Henri Mathe; Amelie Jaspart; Andre Ulmann; Erin Gainer
Journal:  Lancet       Date:  2010-01-29       Impact factor: 79.321

4.  Emergency contraception: potential role of ulipristal acetate.

Authors:  Kristina Gemzell-Danielsson; Chun-Xia Meng
Journal:  Int J Womens Health       Date:  2010-08-09

5.  Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception.

Authors:  Paul Fine; Henri Mathé; Savita Ginde; Vanessa Cullins; Johanna Morfesis; Erin Gainer
Journal:  Obstet Gynecol       Date:  2010-02       Impact factor: 7.661
  5 in total
  2 in total

Review 1.  Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects.

Authors:  Sally Rafie; Rebecca H Stone; Tracey A Wilkinson; Laura M Borgelt; Shareen Y El-Ibiary; Denise Ragland
Journal:  Integr Pharm Res Pract       Date:  2017-03-23

2.  Ulipristal Acetate Interferes With Actin Remodeling Induced by 17β-Estradiol and Progesterone in Human Endometrial Stromal Cells.

Authors:  Jorge E Shortrede; Maria M Montt-Guevara; Gisela Pennacchio; Michele Finiguerra; Andrea Giannini; Alessandro D Genazzani; Tommaso Simoncini
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-27       Impact factor: 5.555
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.